Immunization, Vaccines and Biologicals


The V3P project – project phases

Two phases of implementation

The first phase of the V3P project (September 2011 to March 2013) focused on gathering and analyzing information about country needs, stakeholder concerns and lessons learned from existing price information mechanisms. Based on these findings the working team developed options for a V3P mechanism, sought advice from the V3P steering committee and consulted with stakeholders before developing the first prototype.

Phase Two currently underway is focusing on testing the options in a selected number of countries and further development of the V3P prototype. Once developed, the mechanism will be presented to stakeholders and will then be rolled out and enable eligible countries to participate. In-country impact evaluations and stakeholder consultations are planned towards the end of the project in 2014 and 2015, after which the mechanism will be established and fully operational.

The chart below provides an overview of the two phases.


Phase One:

Objective One - Information gathering and analysis- COMPLETED

Remote and in-country reviews were conducted to gather and analyze country needs and available information on current procurement practices and product attributes affecting vaccine prices.

Reviews of vaccine price and procurement data currently available from large pooled procurement mechanisms such as UNICEF Supply Division, PAHO Revolving Fund and US Centers for Disease Control and Prevention (CDC) with the goal of identifying gaps and opportunities for collaboration and appropriate use of data, information and practices.

Reviews of currently operating mechanisms and tools utilized in the medicines markets for the dissemination of medicines price and procurement information to learn from their experiences and assess adaptabilities for the vaccine market.

Preparation of a stakeholder impact and solutions analysis to maximize benefits, and minimize or mitigate challenges and risks to improved availability of vaccine price and procurement data and information.

Objective Two – Consensus and Development- COMPLETED

Options for method(s), mechanism(s) and/or tool(s) to collect, collate, analyze and disseminate appropriate product, price and procurement information built on the information gained from Objective One were put forward for consideration by the V3P steering committee. A broad consultation process with stakeholders was undertaken in March 2013. The V3P Project welcomes any additional comments to the information presented in this document and is attached below.

Phase Two – IN PROGRESS

Objective Three – Pilot testing

A pilot test of the V3P mechanism is currently being conducted.

During the pilot phase, a utility analysis will provide information on challenges and user requests.

Objective Four – Implementation and roll-out

The results of the pilot testing and assessment will be presented to the V3P steering committee, and more broadly if needed, for their feedback and suggestions for improvement and will be used to inform the design of an appropriate system for the wider community.

Objective Five – Evaluation and sustainability

An impact/outcome assessment will be conducted to determine whether the availability of the mechanism has had an impact on decision making within the target countries, and to ensure sustainability of the established V3P platform.

Share